404
Drug Screening Market Analysis
Drug Screening Market, Dynamics, and Market Analysis- 2022-2028
The report on the Drug Screening Market is segmented by Product & Services (Analytical Instruments, Rapid Testing Devices, Consumables, Drug Screening Services), By Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other), By End User ...
The drug screening market size is expected to reach USD 15.52 billion in the foreseeable future.
Alere Inc. (The U.S), Laboratory Corporation of America Holdings (The U.S), OraSure Technologies (The U.S), Quest Diagnostics (The U.S), Thermo Fisher Scientific (The U.S), Alfa Scientific Designs, Inc. (The U.S), MPD Inc. (The U.S), Lifeloc Technologies, Inc. (The U.S), Omega Laboratories Inc. (The U.S), Sciteck Diagnostics Inc (The U.S), ACM GLOBAL LABORATORIES (The U.S), and Carehealth America Corporation (The U.S) are among the key players in the market.
The market is expected to grow at an impressive CAGR of 16.74% in the coming years.
North America accounted for the largest share of the market in 2021.
The workplace segment accounted for the largest share of the market in 2021.
Increasing drug and alcohol testing measures in various countries to curb the menace of drug and alcohol abuse, an increase in consumption of drugs and alcohol across the geographies, particularly among the youth and elder population are the factors driving the growth of the market.
Drug screening distributors, Drug screening suppliers, Drug screening manufacturers, Logistics organizations, and Government Bodies are the target audience in the market.